These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 38237141)

  • 1. SOX11 is a novel binding partner and endogenous inhibitor of SAMHD1 ara-CTPase activity in mantle cell lymphoma.
    Abdelrazak Morsy MH; Lilienthal I; Lord M; Merrien M; Wasik AM; Sureda-Gómez M; Amador V; Johansson HJ; Lehtiö J; Garcia-Torre B; Martin-Subero JI; Tsesmetzis N; Tao S; Schinazi RF; Kim B; Sorteberg AL; Wickström M; Sheppard D; Rassidakis GZ; Taylor IA; Christensson B; Campo E; Herold N; Sander B
    Blood; 2024 May; 143(19):1953-1964. PubMed ID: 38237141
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinical and biological impact of SAMHD1 expression in mantle cell lymphoma.
    Merrien M; Wasik AM; Ljung E; Morsy MHA; de Matos Rodrigues J; Carlsten M; Rassidakis GZ; Christensson B; Kolstad A; Jerkeman M; Ek S; Herold N; Wahlin BE; Sander B
    Virchows Arch; 2022 Mar; 480(3):655-666. PubMed ID: 34738194
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of SAMHD1 expression and mutation status in mantle cell lymphoma: An analysis of the MCL Younger and Elderly trial.
    Roider T; Wang X; Hüttl K; Müller-Tidow C; Klapper W; Rosenwald A; Stewart JP; de Castro DG; Dreger P; Hermine O; Kluin-Nelemans HC; Grabe N; Dreyling M; Pott C; Ott G; Hoster E; Dietrich S
    Int J Cancer; 2021 Jan; 148(1):150-160. PubMed ID: 32638373
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting SAMHD1 with the Vpx protein to improve cytarabine therapy for hematological malignancies.
    Herold N; Rudd SG; Ljungblad L; Sanjiv K; Myrberg IH; Paulin CB; Heshmati Y; Hagenkort A; Kutzner J; Page BD; Calderón-Montaño JM; Loseva O; Jemth AS; Bulli L; Axelsson H; Tesi B; Valerie NC; Höglund A; Bladh J; Wiita E; Sundin M; Uhlin M; Rassidakis G; Heyman M; Tamm KP; Warpman-Berglund U; Walfridsson J; Lehmann S; Grandér D; Lundbäck T; Kogner P; Henter JI; Helleday T; Schaller T
    Nat Med; 2017 Feb; 23(2):256-263. PubMed ID: 28067901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ribonucleotide reductase inhibitors suppress SAMHD1 ara-CTPase activity enhancing cytarabine efficacy.
    Rudd SG; Tsesmetzis N; Sanjiv K; Paulin CB; Sandhow L; Kutzner J; Hed Myrberg I; Bunten SS; Axelsson H; Zhang SM; Rasti A; Mäkelä P; Coggins SA; Tao S; Suman S; Branca RM; Mermelekas G; Wiita E; Lee S; Walfridsson J; Schinazi RF; Kim B; Lehtiö J; Rassidakis GZ; Pokrovskaja Tamm K; Warpman-Berglund U; Heyman M; Grandér D; Lehmann S; Lundbäck T; Qian H; Henter JI; Schaller T; Helleday T; Herold N
    EMBO Mol Med; 2020 Mar; 12(3):e10419. PubMed ID: 31950591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gene expression profiling and chromatin immunoprecipitation identify DBN1, SETMAR and HIG2 as direct targets of SOX11 in mantle cell lymphoma.
    Wang X; Björklund S; Wasik AM; Grandien A; Andersson P; Kimby E; Dahlman-Wright K; Zhao C; Christensson B; Sander B
    PLoS One; 2010 Nov; 5(11):e14085. PubMed ID: 21124928
    [TBL] [Abstract][Full Text] [Related]  

  • 7. MiR-132-3p serves as a tumor suppressor in mantle cell lymphoma via directly targeting SOX11.
    Wu B; Li J; Wang H; Wu Q; Liu H
    Naunyn Schmiedebergs Arch Pharmacol; 2020 Nov; 393(11):2197-2208. PubMed ID: 32040593
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Stabilization of SAMHD1 by NONO is crucial for Ara-C resistance in AML.
    Zhang F; Sun J; Tang X; Liang Y; Jiao Q; Yu B; Dai Z; Yuan X; Li J; Yan J; Zhang Z; Fan S; Wang M; Hu H; Zhang C; Lv XB
    Cell Death Dis; 2022 Jul; 13(7):590. PubMed ID: 35803902
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SOXC transcription factors in mantle cell lymphoma: the role of promoter methylation in SOX11 expression.
    Wasik AM; Lord M; Wang X; Zong F; Andersson P; Kimby E; Christensson B; Karimi M; Sander B
    Sci Rep; 2013; 3():1400. PubMed ID: 23466598
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-resolution chromatin immunoprecipitation (ChIP) sequencing reveals novel binding targets and prognostic role for SOX11 in mantle cell lymphoma.
    Kuo PY; Leshchenko VV; Fazzari MJ; Perumal D; Gellen T; He T; Iqbal J; Baumgartner-Wennerholm S; Nygren L; Zhang F; Zhang W; Suh KS; Goy A; Yang DT; Chan WC; Kahl BS; Verma AK; Gascoyne RD; Kimby E; Sander B; Ye BH; Melnick AM; Parekh S
    Oncogene; 2015 Mar; 34(10):1231-40. PubMed ID: 24681958
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SAMHD1 is a biomarker for cytarabine response and a therapeutic target in acute myeloid leukemia.
    Schneider C; Oellerich T; Baldauf HM; Schwarz SM; Thomas D; Flick R; Bohnenberger H; Kaderali L; Stegmann L; Cremer A; Martin M; Lohmeyer J; Michaelis M; Hornung V; Schliemann C; Berdel WE; Hartmann W; Wardelmann E; Comoglio F; Hansmann ML; Yakunin AF; Geisslinger G; Ströbel P; Ferreirós N; Serve H; Keppler OT; Cinatl J
    Nat Med; 2017 Feb; 23(2):250-255. PubMed ID: 27991919
    [TBL] [Abstract][Full Text] [Related]  

  • 12. SOX11 promotes tumor protective microenvironment interactions through CXCR4 and FAK regulation in mantle cell lymphoma.
    Balsas P; Palomero J; Eguileor Á; Rodríguez ML; Vegliante MC; Planas-Rigol E; Sureda-Gómez M; Cid MC; Campo E; Amador V
    Blood; 2017 Jul; 130(4):501-513. PubMed ID: 28533307
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Relationship of Expression Between SOX11 and PAX5 in Pathological Tissue Specimens of Patients with Mantle Cell Lymphoma and Its Clinical Significance].
    Jing CX; Feng Y; Cao X; Xu CG
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2020 May; 51(3):355-360. PubMed ID: 32543142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOX11, a key oncogenic factor in mantle cell lymphoma.
    Beekman R; Amador V; Campo E
    Curr Opin Hematol; 2018 Jul; 25(4):299-306. PubMed ID: 29738333
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Regulation of SOX11 expression through CCND1 and STAT3 in mantle cell lymphoma.
    Mohanty A; Sandoval N; Phan A; Nguyen TV; Chen RW; Budde E; Mei M; Popplewell L; Pham LV; Kwak LW; Weisenburger DD; Rosen ST; Chan WC; Müschen M; Ngo VN
    Blood; 2019 Jan; 133(4):306-318. PubMed ID: 30530749
    [TBL] [Abstract][Full Text] [Related]  

  • 16. SOX11 augments BCR signaling to drive MCL-like tumor development.
    Kuo PY; Jatiani SS; Rahman AH; Edwards D; Jiang Z; Ahr K; Perumal D; Leshchenko VV; Brody J; Shaknovich R; Ye BH; Parekh S
    Blood; 2018 May; 131(20):2247-2255. PubMed ID: 29615403
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX11 regulates PAX5 expression and blocks terminal B-cell differentiation in aggressive mantle cell lymphoma.
    Vegliante MC; Palomero J; Pérez-Galán P; Roué G; Castellano G; Navarro A; Clot G; Moros A; Suárez-Cisneros H; Beà S; Hernández L; Enjuanes A; Jares P; Villamor N; Colomer D; Martín-Subero JI; Campo E; Amador V
    Blood; 2013 Mar; 121(12):2175-85. PubMed ID: 23321250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of V-ATPase as a molecular sensor of SOX11-levels and potential therapeutic target for mantle cell lymphoma.
    Emruli VK; Olsson R; Ek F; Ek S
    BMC Cancer; 2016 Jul; 16():493. PubMed ID: 27430213
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Knock-down of SOX11 induces autotaxin-dependent increase in proliferation in vitro and more aggressive tumors in vivo.
    Conrotto P; Andréasson U; Kuci V; Borrebaeck CA; Ek S
    Mol Oncol; 2011 Dec; 5(6):527-37. PubMed ID: 21880559
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Flow cytometric analysis of SOX11: a new diagnostic method for distinguishing B-cell chronic lymphocytic leukemia/small lymphocytic lymphoma from mantle cell lymphoma.
    Wasik AM; Priebe V; Lord M; Jeppsson-Ahlberg Å; Christensson B; Sander B
    Leuk Lymphoma; 2015 May; 56(5):1425-31. PubMed ID: 25120048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.